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By diversifying the biological effector functions of
antibodies, class switch DNA recombination (CSR)
plays a critical role in the maturation of the immune
response. It is initiated by activation-induced cyti-
dine deaminase (AID)-mediated deoxycytosine
deamination, yielding deoxyuridine (dU), and dU
glycosylation by uracil DNA glycosylase (Ung) in
antibody switch (S) region DNA. Here we showed
that the translesion DNA synthesis polymerase
Rev1 directly interacted with Ung and targeted in
an AID-dependent and Ung-independent fashion
the S regions undergoing CSR. Rev1/ Ung+/+ B
cells reduced Ung recruitment to S regions, DNA-
dU glycosylation, and CSR. Together with an S
region spectrum of mutations similar to that of
Rev1+/+ Ung/B cells, this suggests that Rev1 oper-
ates in the same pathway as Ung, as emphasized by
further decreased CSR in Rev1/ Msh2/ B cells.
Rescue of CSR in Rev1/ B cells by a catalytically
inactive Rev1 mutant shows that the important role
of Rev1 in CSR is mediated by Rev1’s scaffolding
function, not its enzymatic function.
INTRODUCTION
Class switch DNA recombination (CSR) and somatic hypermuta-
tion (SHM) are critical for maturation of the antibody response.
CSR endows antibodies with new biological effector functions
by replacing the CH region with a CH region that lies downstream
in the immunoglobulin heavy chain (IgH) locus (Xu et al., 2012).
SHM provides the structural substrate for antigen-mediated
selection of higher-affinity antibody mutants by introducing
mainly point mutations with rare deletions or insertions into a re-
arranged Ig V(D)J sequence (Casali et al., 2006). Both CSR and
SHM involve activation-induced cytidine deaminase (AID)-medi-
ated generation of DNA lesions and subsequent DNA repair (Liu
and Schatz, 2009; Xu et al., 2012). AID deaminates deoxycyto-1220 Cell Reports 2, 1220–1232, November 29, 2012 ª2012 The Autsine (dC) residues to yield deoxyuridine (dU):deoxyguanine
(dG) mispairs. These mispairs then trigger DNA repair processes
that lead to the introduction of mutations in V(D)J regions and
generation of double-strand DNA breaks (DSBs) in switch (S)
regions into which point mutations are also introduced (Odegard
and Schatz, 2006; Xu et al., 2012). Resolution of DSBs by ligation
of an upstream and a downstream S region leads to CSR (Xu
et al., 2012).
Upon induction by CD40 or TLR signaling (Pone et al., 2012b)
of specific transcription factors, including HoxC4 and NF-kB
(Mai et al., 2010; Park et al., 2009; Tran et al., 2010; White
et al., 2011), AID is expressed at high levels and targeted
by 14-3-3 adaptors to S region DNA to generate dUs (Xu
et al., 2010). These dUs can be ‘‘replicated over’’ to introduce
dC/dG transition mutations or can be processed through the
base excision repair (BER) pathway, involving glycosylation by
uracil DNA glycosylase (Ung) and abasic site excision by apur-
inic/apyrimidinic endonucleases (APEs), thereby giving rise to
DSBs (Stavnezer, 2011; Xu et al., 2012). Ung-mediated dU
glycosylation initiates the major process leading to generation
of DSBs and CSR (Rada et al., 2002). dU:dG mispairs can also
be dealt with by the mismatch repair (MMR) machinery, which
can contribute to the generation of S region DSBs (Rada et al.,
2004). Accordingly, combined deficiency of Ung and Msh2,
a critical MMR element, leads to ablation of CSR (Rada et al.,
2004). Translesion DNA synthesis (TLS) polymerases, including
polymerases h, q, z, and Rev1, are involved in the DNA lesion
repair leading to SHM (Casali et al., 2006; Jansen et al., 2006;
Weill and Reynaud, 2008; Zan et al., 2001, 2005), and DNA poly-
merases b and z are perhaps also involved in repairing S region
DSBs (Schenten et al., 2009; Wu and Stavnezer, 2007). The role
of DNA polymerases in CSR, however, remains to be defined.
Rev1 is one of only a few eukaryotic DNA polymerases that
possess both catalytic and structural functions (i.e., recruitment
of other factors) for DNA repair. In its catalytic role, Rev1, a Y
family TLS polymerase, inserts dCs opposite from template
dUs, abasic sites, and other damaged bases by utilizing a unique
mechanism of protein-template-directed nucleotide incorpora-
tion (Nair et al., 2005; Prakash et al., 2005; Zhang et al., 2002).
However, the dC transferase catalytic activity, as well as the
N-terminal BRCA1 C terminus (BRCT) domain of Rev1, arehors
largely dispensable for efficient TLS and hence tolerance of DNA
damage caused by a different mutagens (Masuda et al., 2009;
Otsuka et al., 2005; Ross et al., 2005). Rev1 plays a role in
SHM (Jansen et al., 2006; Masuda et al., 2009). In a study in
Rev1/ mice, the Ig Vl gene mutation spectrum was shown
to be altered: dC/dG transversions were virtually absent in
the nontranscribed (coding) strand and reduced in the tran-
scribed strand (Jansen et al., 2006). The sharing of many DNA
repair factors between SHM and CSR and the multiple functions
of Rev1 in DNA repair, through interactions with different DNA
repair factors (Hicks et al., 2010; Sharma et al., 2011; Xie et al.,
2010), prompted us to hypothesize that Rev1 is involved in
CSR by interacting with other elements of the CSR machinery
and enhancing their function/activity.
We addressed the role of Rev1 in CSR in vivo and in vitro using
Rev1/mice injected with 4-hydroxy-3-nitrophenyl acetyl (NP)-
conjugated chicken gamma globulin (NP-CGG) and B cells
deficient in Rev1 or other CSR factors, including AID and Ung.
We adapted bimolecular fluorescence complementation (BiFC)
assays to study the direct interaction of Rev1 with Ung and
Ung mutants. We performed chromatin immunoprecipitation
(ChIP) assays using B cells deficient in AID, Rev1, or Ung to
determine the AID dependence of Rev1 recruitment to S regions,
as well as the role of Rev1 in recruitment of Ung to S regions. We
also enforced expression of Rev1 mutants in Rev1/ B cells to
rescue CSR in the absence of Rev1 catalytic activity. Finally, we
generated double-knockout Rev1/ Msh2/ mice to ascertain
whether Rev1 deficiency would virtually abrogate CSR when
paired withMsh2 deficiency, as does Ung deficiency. Our exper-
iments reveal an important noncatalytic (scaffold) role of Rev1 in
CSR: Rev1 recruits and/or stabilizes Ung to/on S regions and
enhances Ung glycosylation activity.
RESULTS
If Rev1 is important in CSR, it should be expressed in germinal
centers, where B cells undergo CSR at a high rate. Indeed, we
found that, like AID, Rev1 protein was expressed in human tonsil
germinal centers (Figure S1A). Accordingly, Rev1 expression
was upregulated together with upregulation of critical CSR
factors, including AID, Ung, HoxC4, and 14-3-3g (real-time
quantitative PCR [qPCR]) in mouse spleen and lymph nodes,
which contain a large proportion of hypermutating and switching
B cells, but not in nonlymphoid organs (Figure S1B). Stimulation
of B cells with bacterial lipopolysaccharides (LPS), LPS or
CD154 plus IL-4, or LPS plus IFN-g, which induce CSR
to different Ig isotypes, upregulated Rev1 expression (Fig-
ure S1C), and this was associated with upregulation of AID,
Ung, HoxC4, and 14-3-3g and CSR (not shown). Thus, Rev1 is
induced by CSR-inducing stimuli and is upregulated in B cells
undergoing CSR.
Rev1 Deficiency Impairs the Class-Switched Antibody
Response to NP-CGG
WeusedRev1/mice (Jansen et al., 2006) to address the role of
Rev1 in CSR in vivo. If Rev1 plays an important role in CSR, its
deficiency should lead to a significant impairment of Ig class
switching in a specific antibody response. In unintentionallyCell Reimmunized Rev1/ mice, serum IgM titers were normal (not
shown), but serum IgG1 and IgG3 concentrations were signifi-
cantly lower than in their Rev1+/+ littermates and comparable
to those of age- and sex-matched Ung/ mice (Figure S2A).
We injected five pairs of 8- to 10-week-old littermate Rev1/
and Rev1+/+ mice with NP16-CGG, boosted 21 days later, and
measured serum total and NP-binding IgM and IgG1 titers
7 days after booster injection. Rev1/ mice showed reduced
levels of total IgG1, NP30-binding IgG1, and high-affinity NP3-
binding IgG1, but not total IgM, NP30-, or NP3-binding IgM as
compared with Rev1+/+ mice (Figure 1A).
The defective NP-binding IgG1 antibody response in Rev1/
mice did not result from alteration of plasma cell or NP-specific
memory B cell differentiation, because the proportions of
(plasma)B220loCD138+cells and (memory)CD38hi Bcells among
NP-binding IgG1 B cells in Rev1/ mice were comparable to
those of theirRev1+/+ littermates (Figures 1B and 1C). In addition,
it was not due to obvious defects in lymphoid differentiation,
because in the Rev1/ mice, the size of the spleen and lymph
nodes, and the number and size of the Peyer’s patches were
normal (not shown), as were the numbers of B and (CD4+ and
CD8+) T cells (Figures 1D and 1E). In Rev1/ mice, B cell prolif-
eration and viability were also normal (Figures 1F and 1G).
Furthermore, after stimulationwith LPS or LPSplus IL-4,Rev1/
B lymphocytes showed cell-cycle parameters and cell-division
rates comparable to those observed for Rev1+/+ cells (Fig-
ures S3A and S3B). Rev1/ mice, however, showed reduced
germinal center IgG1+ PNAhiB220+ B cells (by 58% in the spleen)
and IgA+ PNAhiB220+ B cells (by 46% in Peyer’s patches; Fig-
ures 1H and 1I). Thus, in spite of normal B cell proliferation and
normal plasma cell and memory B cell differentiation, Rev1 defi-
ciency impairs a specific class-switched antibody response,
likely because of an intrinsic impairment in the CSR machinery.
Rev1 Deficiency Impairs CSR
To further determine the impact of Rev1 deficiency on CSR, we
stimulated Rev1/ and Rev1+/+ (spleen) B cells with LPS (to
induce switching to IgG2b and IgG3), CD154 (IgG2b), LPS or
CD154 plus IL-4 (IgG1 and IgE), LPS or CD154 plus IFN-g
(IgG2a), and LPS or CD154 plus TGF-b1, IL-5, IL-4, and anti-d
monoclonal antibody (mAb)/dex (IgA). After 4 days, there
were fewer switched surface Igg1+, Igg2a+, Igg3+, and Iga+ B
cells (by as much as 61%, 75%, 91%, and 76%, respectively)
among Rev1/ compared with Rev1+/+ B cells (Figures S3C
and S3D). Accordingly, secreted IgG1, IgG2a, IgG2b, IgG3,
IgA, and IgE, but not IgM, were reduced in Rev1/ B cell
cultures (Figure 2A), despite the normal cell cycle and prolifera-
tionRev1/B cells (Figures S3A, S3B, 2B, and 2C), and compa-
rable numbers of CD138+B220lo plasma cells emerging from
Rev1/ and Rev1+/+ B cells (Figure 2D). Although the CSR (to
IgG1 and IgG3) impairment in Rev1/ B cells was profound, it
did not match that of Ung/ B cells, as assessed by switched
surface Igg1 and Igg3 expression (Figure S2B). However, it
resulted in secreted IgG1 and IgG3 levels virtually as low as
those of Ung/ B cells in vivo and in vitro (IgG3; Figures S2A
and S2C). The reduced CSR in Rev1/ B cells reflected
decreased (by asmuch as 83%) circle IH-Cm transcripts (byprod-
ucts of CSR) and post-recombination Im-CH transcripts (resultingports 2, 1220–1232, November 29, 2012 ª2012 The Authors 1221
Figure 1. Rev1 Deficiency Impairs the Class-Switched Antibody Response
(A) Titers of circulating IgM and IgG1, NP30-binding IgM and IgG1, and high-affinity NP3-binding IgM and IgG1 inRev1
+/+ andRev1/ littermates, immunizedwith
NP16-CGG and boosted 21 days later (n = 3–5 pairs of mice; each symbol represents an individual mouse), measured 7 days after the booster injection, and
expressed as mg equivalent per ml (mgeq/ml) or the number of dilutions needed to reach 50% of saturation binding (EC50); p values, paired t test.
(B and C) Normal plasma cell and memory B cell differentiation in Rev1+/+ and Rev1/ littermates 14 days after immunization with NP16-CGG (flow cytometry
analysis). (B) B220loCD138+ (plasma) cells as percentage of total spleen cells. (C) CD38+ memory B cells as percentage of total NP-binding surface IgG1+ B cells.
Cells were stained with phycoerythrin (PE)-labeled B220 mAb, fluorescein isothiocyanate-peanut agglutinin (FITC-PNA), PE-NP, APC-mAb to mouse IgG1, and
PECy7-mAb to mouse CD38.
(D and E) Normal proportions of B cells, CD4+ T cells, and CD8+ T cells in Rev1/ mice. Spleen cells from Rev1+/+ and Rev1/ littermates were stained for
surface B220 and CD4 (D) or CD4 and CD8 (E) using PE-labeled B220 mAb, FITC-labeled CD4 mAb, and peridinin-chlorophyll-protein complex (PerCP)-labeled
CD8 mAb.
(F) In vivo proliferation of B cells from spleens of 10-week-old Rev1+/+ and Rev1/ mice immunized with NP16-CGG and injected 10 days later with BrdU (1 mg)
twice within 16 hr. B cells were analyzed 4 hr after the final injection. Cells were stained with PE-labeled B220 mAb; incorporated BrdU was detected by flow
cytometry with APC-labeled mAb to BrdU.
(G) Normal viability (7-AAD) of Rev1/ B cells. Spleen cells from Rev1/ and Rev1+/+ littermates were stained with 7-AAD and PE-labeled B220 mAb.
(H and I) In vivo CSR inRev1+/+ and Rev1/ littermates. (H) Spleen cells fromRev1+/+ andRev1/mice 14 days after immunization with NP16-CGGwere stained
with FITC-labeled PNA, PE-labeled B220 mAb, and APC-labeled anti-igG1 mAb; class-switched germinal center B cells are IgG1+PNAhi B220+. (I) Cells from
Peyer’s patches of 12-week-old unintentionally immunizedRev1+/+ andRev1/micewere stainedwith Alexa Fluor 647-labeled PNA, PE-labeled B220mAb, and
FITC-labeled anti-igA mAb; class-switched B cells are sIgA+ PNAhiB220+. Data are from one representative experiment of three independent experiments using
B cells from three pairs of mice.
See also Figure S2.from CSR, reduced by asmuch as 86%) in these B lymphocytes,
in spite of the normal levels of germline IH-CH (Ig1-Cg1, Ig2a-
Cg2a, Ig2b-Cg2b, Ig3-Cg3, Ia-Ca, and Iε-Cε) transcripts, which
precede DNA recombination, and normal expression of Aicda
and Ung transcripts as well as AID and Ung proteins (Figures
2E, 2F, and 3). Thus, Rev1 deficiency impairs CSR to all class-
switched Ig isotypes without affecting germline IH-CH transcrip-
tion or AID and Ung expression.
Rev1/ B Cells Show an Altered Mutation Spectrum
in S Region DNA
Mutations arise in S region DNA in B cells undergoing CSR (Maul
and Gearhart, 2010). To ascertain whether defective CSR in
Rev1/Ung+/+ B cells was associated with altered mutations
in S regions, we sequenced the upstream region of Sm DNA
(nucleotides 4289–5168; GenBank accession number J0040),
which includes the sequence analyzed by others (Rada et al.,
2002), and compared the mutations with those in B cells from1222 Cell Reports 2, 1220–1232, November 29, 2012 ª2012 The AutRev1+/+ Ung+/+ littermates and Rev1+/+ Ung/ mice. In B cells
from Rev1/Ung+/+ mice, the mutation frequency in Sm was
increased by almost 30% (p = 0.003) as compared with their
Rev1+/+Ung+/+ littermates. An even greater increase in mutation
frequency was detected in B cells from Rev1+/+Ung/ mice,
possibly due to a more severe defect in (error-free) DNA repair
associated with Ung deficiency and/or simply to interstrain vari-
ations. Remarkably, although dC/dT or dG/dA transitions
accounted for 53.7% of the mutations at dC/dG pairs in Rev1+/+
Ung+/+ B cells, they accounted for 86% of the dC/dG mutations
in Rev1/Ung+/+ B cells (p < 0.0001; Figure 4), a phenotype
resembling that of Rev1+/+Ung/ B cells (p = 0.98), suggesting
that Rev1 and Ung function in the same CSR pathway.
Rev1 Is Recruited to S Regions in an AID-Dependent
Fashion to Recruit/Stabilize Ung
We further addressed the role of Rev1 in CSR by analyzing
its recruitment to S regions. In B cells stimulated with LPS plushors
Figure 2. Impaired CSR in Rev1/ B Cells
(A) Ig titers in supernatants of cultures of Rev1+/+ and Rev1/ B cells stimulated for 7 days with LPS (IgG2b and IgG3) or CD154 (IgG2b), or with LPS or CD154
plus IL-4 (IgM, IgG1, and IgE), IFN-g (IgG2a) or TGF-b1, IL-4, IL-5, and anti-dmAb/dex (IgA); p values, paired t test. Data are from experiments with spleen B cells
from three to five pairs of Rev1+/+ and Rev1/ mice.
(B and C) Impaired CSR in Rev1/ B cells is not due to alteration in cell proliferation. Proliferation of Rev1+/+ and Rev1/ B cells labeled with the cell division
tracking fluorochrome carboxyfluorescein succinimidyl ester (CFSE) and stimulated with (B) LPS or LPS plus IL-4, or (C) CD154 or CD154 plus IL-4. Depicted are
sIgG1+ cells amongB lymphocytes that had been stimulated for 4 days and completed the same number of divisions inRev1+/+ andRev1/Bcells. Data are from
one representative experiment of three independent experiments.
(D) Normal plasma cell differentiation in Rev1/ B cells. Rev1+/+ and Rev1/ B cells were stimulated for 4 days with LPS, LPS plus IL-4, or CD154 plus IL-4, as
analyzed by surface expression of B220 and CD138. Numbers in outlined areas indicate percent B220loCD138+ (plasma) cells among total cells. Data are from
one representative experiment of three independent experiments.
(E and F) Normal Aicda and Ung expression in Rev1/ B cells.
(E) Real-time qPCR analysis of Aicda and Ung mRNAs in spleen Rev1+/+ and Rev1/ B cells cultured for 60 hr with LPS plus IL-4. Expression is normalized to
Cd79b expression and relative to the expression in Rev1+/+ B cells, set as one. Data are from three independent experiments (mean and SEM).
(F) Protein levels of Ung, AID, and b-actin in cell lysates from spleen Rev1+/+ and Rev1/ B cells cultured for 60 hr with LPS plus IL-4.
See also Figures S1, S2, and S3.IL-4, which induces CSR to IgG1 but not to IgG3, ChIP assays
showed that both Rev1 and Ung bound to Sg1 but not to Sg3
DNA; conversely, in B cells stimulated with LPS, which induces
CSR to IgG3 but not to IgG1, Rev1 and Ung were recruited to
Sg3 but not to Sg1. Both Rev1 and Ung were recruited to Sm.
As with Ung (Ranjit et al., 2011), Rev1 recruitment to S region
DNA was abrogated in Aicda/ B cells, indicating that Rev1 isCell Rerecruited to S regions in response to AID-mediated lesions in
DNA (Figure 5A). To determine whether Rev1 and Ung binding
to S region DNA is interdependent, we performed ChIP assays
utilizing Rev1 and Ung Abs in both Rev1/ and Ung/ B cells.
Ung binding to Sg1 and Sg3 DNA was impaired in Rev1/
B cells stimulated with LPS plus IL-4 and LPS, respectively,
whereas Rev1 recruitment to Sg1 and Sg3 DNAwas not affectedports 2, 1220–1232, November 29, 2012 ª2012 The Authors 1223
Figure 3. Decreased Circle IH-Cm and Post-
recombination Im-CH Transcripts, but Not
Germline IH-CH Transcripts, in Rev1
/ B
Cells
Real-time qPCR analysis of germline IH-CH tran-
scripts (top), circle IH-Cm transcripts (middle), and
post-recombination Im-CH transcripts (bottom) in
Rev1+/+ and Rev1/ B cells cultured for 60 hr with
LPS (Ig2b-Cg2b, Ig3-Cg3, Ig2b-Cm, Ig3-Cm, Im-
Cg2b, and Im-Cg3), CD154 (Ig2b-Cg2b, Ig2b-Cm
and Im-Cg2b), or LPS or CD154 plus IL-4 (Ig1-Cg1,
Iε-Cε, Ig1-Cm, Iε-Cm, Im-Cg1, and Im-Cε), IFN-g
(Ig2a-Cg2a, Ig2a-Cm, and Im-Cg2a), or TGF-b1,
IL-4, IL-5, and anti-d mAb/dex (Ia-Ca, Ia-Cm, and
Im-Ca). Expression of germline IH-CH, circle IH-Cm,
and post-recombination Im-CH transcripts was
normalized to Cd79b expression and is depicted
as relative to expression in Rev1+/+ B cells, set as
one. **p < 0.01, paired t test. Data are from three
independent experiments (mean and SEM).by Ung deficiency (Ung/ B cells), showing that the occupancy
of S region DNA by Ung is dependent on Rev1, but occupancy of
S region DNA by Rev1 is independent of Ung. Thus, Rev1 plays
a role in recruiting and/or stabilizing Ung to/on S region DNA.
Rev1 Interacts Directly with Ung
If Rev1 is important for Ung recruitment/stabilization to/on S
region DNA, then it must interact with Ung. To establish whether
Rev1 can interact directly with Ung, rather than through a
third-party molecule, we adapted an ad hoc BiFC assay (Xu
et al., 2010). We divided a superenhanced yellow fluorescent
protein (sEYFP) coding sequence into two complementary moie-
ties: one encoding the N-terminal 154 residues (sEYFP1–154)
and one encoding the C-terminal 84 residues (sEYFP155–238).
These were fused with Flag-tagged human Ung (Flag-Ung-
sEYFP1–154) and influenza hemagglutinin (HA)-tagged human
Rev1 (HA-Rev1-sEYFP155–238), respectively (Figure 5B). Once
expressed, the two sEYFP moieties complemented each other
and gave off a strong yellow fluorescence as a result of direct
juxtaposition between Rev1 and Ung. Had Rev1 and Ung inter-
acted through a third ‘‘spacer’’ molecule, this would have pre-
vented sEYFP1–154 and sEYFP155–238 from complementing
each other and therefore giving off fluorescence. We then tested
whether the interaction between Rev1 and Ung occurred
through the Ung N-terminal region, which contains the prolifer-
ating cell nuclear antigen (PCNA)/replication protein A (RPA)
interaction domain and RPA interaction domain, or the Ung
C-terminal region, which contains the 231WxxF234 motif. BiFC
assays involving human Rev1 and human Ung mutants con-
taining 151 N-terminal residues (Flag-Ung1–151-sEYFP1–154) or
229 C-terminal residues (Flag-Ung85–313-sEYFP1–154) showed1224 Cell Reports 2, 1220–1232, November 29, 2012 ª2012 The Authorsthat Rev1 interacted with Ung through
the Ung C-terminal region but not the
N-terminal region (Figures 5C and 5D).
Next, we determined whether the Ung
231WxxF234 motif was involved in the
interaction with Rev1. Ung mutants ofthe WxxF motif lacking the N-terminal region failed to restore
CSR in Ung/ B cells (Begum et al., 2009). We performed
BiFC assays using human Ung molecules lacking N-terminal
1–84 amino acid residues and bearing the W231A, W231K,
F234G, or F234Dmutation in the 231WxxF234motif. Each of these
mutations reduced the ability of mouse UngD1-86 to mediate CSR
in Ung/ B cells, without affecting Ung protein levels (Begum
et al., 2009). Accordingly, none of the four WxxF mutations
(W231A, W231K, F234G, or F234D) altered human Ung protein
levels, but each impaired Ung interaction with Rev1 (Figures
5D and 5E). Thus, Rev1 interacts directly with Ung through the
Ung 231WxxF234 motif to mediate CSR.
Rev1 Deficiency Impairs B Cell Ung Activity
To investigate whether in addition to recruiting/stabilizing Ung
to/on S region DNA, Rev1 also enhances Ung function, we
used a double-strand DNA substrate containing an internal
dU:dG mispair to analyze the DNA-dU glycosylation activity of
extracts from Rev1+/+Ung+/+, Rev1/Ung+/+, or Rev1+/+Ung/
B cells that had been stimulated with LPS plus IL-4. Whereas
Rev1
+/+
Ung+/+ B cell extracts displayed abundant DNA-dU
glycosylation activity, extracts from Rev1/Ung+/+ B cells,
in which Ung messenger RNA (mRNA) and protein levels
were comparable to those in Rev1+/+Ung+/+ B cells (Figures
2E and 2F), showed a 75% reduction of DNA-dU glycosyla-
tion as compared with Rev1+/+Ung+/+ B cells (Figure 4F).
Rev1+/+Ung/ B cell extracts showed only minimal residual
DNA-dU glycosylation (5%, possibly due to the expression of
DNA glycosylases other than Ung, such as Smug1). Thus,
Rev1 enables or enhances Ung DNA-dU glycosylation function
in B cells.
Figure 4. Altered Spectrum of Somatic
Mutations at dC/dG of the Sm Region in
Rev1/Ung+/+ Mice
Sm region DNAwas amplified fromPeyer’s patch B
cells from three 12-week-old Rev1+/+Ung+/+ and
three Rev1/ Ung+/+ littermates and three age-
matched Rev1+/+Ung/ mice. Pie charts depict
the proportions of sequences that carry one, two,
three, etc., mutations over the 880 bp Sm DNA
analyzed. The numbers of sequences analyzed
are at the center of the pies. Middle and bottom
panels depict patterns of mutations. Values are
expressed as the actual numbers of different
nucleotide substitutions (middle panels) or as
the percentage of total mutations. Below the
compilations, the ratio of transition/transversion
substitutions at dC/dG is indicated; p values, chi-
squared test.Double Deficiency in Rev1 and Msh2 Further Impairs
CSR
We reasoned that if Rev1 is important in recruitment/stabilization
of Ung to/on S regions and critically enhances the activity of this
enzyme, then the CSR defect brought about by Rev1 deficiency
should compound that due to Msh2 deficiency, in much the
same way that Ung deficiency abrogates CSR when combined
with Msh2 deficiency, as in Ung/Msh2/ B cells, in which
both Ung-dependent and Msh2-dependent CSR pathways
are aborted (Rada et al., 2004). We crossbred Rev1/ with
Msh2/ mice to construct double-knockout Rev1/Msh2/
mice. In Rev1/Msh2/ B cells, CSR to IgG1, IgG3, IgG2a,
or IgA was reduced by up to 96% as compared with Rev1+/+
Msh2+/+, and 50%–60% as compared with single-knockout
Rev1/Msh2+/+ or Rev1+/+Msh2/ B cells, as shown by
surface Ig expression; secreted IgG1, IgG2a, IgG3, and IgA;
and recombinant Sm-Sg1 and Sm-Sg3 DNA detected by diges-
tion-circularization PCR (DC-PCR; Figure 6). Accordingly, in
Rev1/Msh2/ B cells, circle IH-Cm and post-recombination
Im-CH transcripts were decreased by as much as 98% (Ig2a-
Cm in B cells stimulated with LPS plus INF-g) and 93% (Im-
Cg2a in B cells stimulated by LPS plus INF-g), respectively, as
compared with Rev1+/+ Msh2+/+ B cells (Figure S4). They were
also reduced as compared with Rev1/ Msh2+/+ B cells (by
95% and 77%, respectively) and Rev1+/+ Msh2/ B cells (by
91% and 65%, respectively). Thus, double Rev1/Msh2 defi-
ciency further impairs CSR due to Msh2 deficiency, suggesting
that Rev1 and Ung function in the same CSR pathway.
Enforced Expression of Catalytically Inactive Rev1
in Rev1/ B Cells Rescues CSR
Our experiments strongly suggested that defective CSR in
Rev1/ B cells was largely due to an impairment in recruit-
ment/stabilization of Ung, which led us to hypothesize that
Rev1 functions in CSR not as an enzyme, but rather as a struc-Cell Reports 2, 1220–1232, Notural (scaffold) element. To test our
hypothesis, we enforced expression of
five different human Rev1 cDNAs in
Rev1/ B cells using constructs based
on the S-003 retroviral expression vector (Sayegh et al., 2003):
(1) wild-type Rev1, (2) Rev1D570A/E571A (a mutant with two point
mutations in the central region, inactivating Rev1 catalytic
activity), (3) Rev11-827 (a C-terminal region truncation mutant
retaining the central and N-terminal regions), (4) Rev1333-1251
(an N-terminal region truncation mutant retaining the central
and C-terminal regions), or (5) Rev1D334-826 (a truncation mutant
lacking the central region and therefore the DNA-binding
domain; Figure 7A). In every case, enforced expression of
Rev1D570A/E571A, Rev11-827, or Rev1333-1251 in Rev1
/ B cells
rescued CSR to IgG1 at the level of wild-type Rev1, whereas
enforced expression of Rev1D334-826 did not, as assessed by
IgG1 surface fluorescence analysis and quantitation of circle
Ig1-Cm and post-recombination Im-Cg1 transcripts (Figures 7B
and 7C). Thus, the Rev1 scaffold function mediated by the
central region of the molecule, but not Rev1 enzymatic activity,
is required for CSR.
DISCUSSION
CSR entails (1) AID deamination of dCs in the IgH locus S regions
to yield dUs and dU glycosylation by Ung, leading to DSBs, and
(2) DSB repair by the combined intervention of DNA replication
and repair factors. As a highly regulated biological process,
CSR is mediated by a multicomponent complex whose
assembly is made possible by scaffold proteins (Xu et al.,
2012). As exemplified by our previous findings on 14-3-3 adap-
tors (Xu et al., 2010), such scaffold proteins can simultaneously
interact with DNA and client proteins through different subunits
or domains to greatly increase the specificity and efficiency of
the CSR macromolecular machinery. Here we show that the
Rev1 TLS polymerase plays an important scaffold role in CSR.
Like AID and other critical CSR factors, such as Ung, HoxC4,
and 14-3-3, it is induced by T-dependent (CD154:C40 engage-
ment) and T-independent (TLR engagement) CSR-inducingvember 29, 2012 ª2012 The Authors 1225
Figure 5. Rev1 Is Recruited to S Regions in an AID-Dependent Fashion, and Directly Interacts with Ung to Recruit/Stabilize Ung and Enhance
Ung Catalytic Activity
(A) Rev1 deficiency impairs Ung binding to S region DNA. Wild-type, Rev1/, Ung/, and Aicda/ B cells were stimulated with LPS or LPS plus IL-4 for 48 hr.
Crosslinked chromatin was precipitated using rabbit Abs specific to Rev1, Ung, or preimmune control rabbit IgG. The precipitated Sg1 and Sg3 DNA were
quantified by real-time qPCR. Data are from three experiments, each in triplicate (mean and SEM).
(B) Schematic of human Ung protein. The PCNA/RPA interaction domain, RPA interaction domain, and 231WxxF234 motif are indicated.
(C) Rev1 interacts directly with Ung, as shown by a BiFC analysis of human Rev1 interaction with human Ung or Ung. HeLa cells were transfected with pcDNA3.1
vector or cotransfected with HA-huRev1-YFP155-238 and Flag-Ung-YFP1-154, Flag-Ung1-151-YFP1-154, Flag-Ung85-313-YFP1-154, or Ung WxxF mutant constructs
Flag-UngW231A-YFP1-154, Flag-UngF234G-YFP1-154, or Flag-UngF234Q-YFP1-154, which were generated using the Rev1 interaction-proficient Ung85-313 N-deletion
mutant as template. Cells were stained with 7-AAD to gate for viability. Background fluorescence (defined as the random low-level fluorescence of Flag-YFP1-154
and HA-YFP155-238) was gated out from total fluorescence to determine true positive protein-protein interactions. Data are from one representative experiment of
three experiments.
(D) Interaction of Rev1 with wild-type and different Ung mutants, as measured by specific BiFC assay.
(E) Expression levels of Flag-Ung-YFP1-154, Flag-Ung1-151-YFP1-154, Flag-Ung85-313-YFP1-154, or Ung WxxF mutant Flag-UngW231A-YFP1-154, Flag-UngF234G-
YFP1-154, or Flag-UngF234Q-YFP1-154 fusion proteins in transfected cells (C), as analyzed by immunoblotting using Flag mAb.
(F) Ung dU glycosylation activity in Rev1+/+Ung+/+, Rev1/Ung+/+, and Rev1+/+Ung/ B cells stimulated with LPS plus IL-4 for 60 hr, as measured by incubating
clarified whole-cell extract (5.0, 2.5, 1.25, 0.625, 0.31, or 0.16 mg protein) with a [32P]-labeled double-stranded oligonucleotide containing a single dU:dGmispair.
The reaction products were resolved in 15% Tris-borate-EDTA (TBE)-urea polyacrylamide gels. The presence of the cleaved DNA reflects glycosylation activity.stimuli and is expressed in a B cell differentiation stage-specific
fashion (germinal center B cells). Rev1 is recruited to S region
DNA in an AID-dependent fashion, interacts directly with Ung,
recruits/stabilizes Ung to/on S regions, and enhances Ung-
mediated DNA dU glycosylation. Thus, the important role of
Rev1 in CSR is an expression of the (nonenzymatic) scaffold
function of this TLS polymerase.1226 Cell Reports 2, 1220–1232, November 29, 2012 ª2012 The AutAs a Y family TLS polymerase, Rev1 possesses a unique and
distributive dC transferase catalytic activity (Nair et al., 2005;
Prakash et al., 2005; Zhang et al., 2002). Because of its ability
to interact with PCNA, ubiquitin, and the TLS polymerases
h, i, k, and z, Rev1 is able to recruit other TLS polymerases,
and thus serves multiple functions in different DNA repair
processes (Hicks et al., 2010; Sharma et al., 2011; Xie et al.,hors
Figure 6. Double Rev1 and Msh2 Deficiency Further Reduces CSR
Rev1+/+Msh2+/+, Rev1/Msh2+/+, Rev1+/+Msh2/, and Rev1/Msh2/ B cells were stimulated with LPS alone (for IgG3), LPS, or CD154 plus IL-4 (for IgG1),
IFN-g (for IgG2a), or TGF-b1, IL-4, IL-5, and anti-d mAb/dex (for IgA).
(A) After 4 days of culture, the cells were analyzed for surface expression of B220 and IgG1, IgG2a, IgG3, or IgA by flow cytometry. Data are from one repre-
sentative experiment of three independent experiments.
(B) After 7 days of culture, the supernatants from Rev1+/+Msh2+/+, Rev1/Msh2+/+, Rev1+/+Msh2/, and Rev1/Msh2/ B cells stimulated with LPS alone or
CD154 plus cytokines were collected and analyzed for concentrations of different Ig isotypes. Data were derived using B cells from three sets, each of four
Rev1+/+Msh2+/+, Rev1/Msh2+/+, Rev1+/+Msh2/, and Rev1/Msh2/ mice.
(C) Recombinant Sm-Sg1 or Sm-Sg3 DNAs analyzed by DC-PCR using serially 2-fold diluted HindIII digested and T4 DNA ligase-ligated genomic DNA from
Rev1+/+Msh2+/+, Rev1/Msh2+/+, Rev1+/+Msh2/, or Rev1/Msh2/ B cells stimulated with LPS or LPS plus IL-4 for 4 days. The Gapdh gene was used as
a control for ligation and DNA loading. Data are from one representative experiment of three independent experiments.
See also Figure S4.2010). Like the TLS polymerases h, q, and z, Rev1 is involved in
SHM by bypassing DNA lesions through its catalytic activity
(Jansen et al., 2006; Masuda et al., 2009). Rev1 deficiency has
been associated with a strand-biased defect in dC/ dG trans-
versions in hypermutating V(D)J genes, suggesting that during
SHM, Rev1 preferentially inserts dCs across from dUs and/or
abasic sites introduced by AID and Ung intervention (Jansen
et al., 2006; Masuda et al., 2009). As we have shown here,
despite normal expression of Ung, Rev1/ B cells greatly
increased dC/dG transition mutations in S regions (point muta-
tions are introduced into the recombining S regions by the
CSR machinery), a pattern similar to that of Ung/ B cells, sug-Cell Regesting that Rev1 and Ung participate in the sameCSR pathway.
Thus, in the absence of Rev1 and hence decreased Ung recruit-
ment, the dU residues in S regions would be replicated over,
yielding dC/dG transitions, in the same way they are replicated
over in Ung/ B cells.
The distinct scaffolding and catalytic functions of Rev1 in CSR
and V(D)J SHM, respectively, were also suggested by the obser-
vation that mice expressing a catalytically inactive Rev1 mutant
displayed an altered mutation spectrum in IgH JH-iEm region
DNA, but B cells from these mice revealed normal CSR
in vitro (Masuda et al., 2009). The two different Rev1 functions
(scaffolding and catalytic) are consistent with the divergentports 2, 1220–1232, November 29, 2012 ª2012 The Authors 1227
Figure 7. Enforced Expression of Catalytically Inactive Rev1 Mutant, N-Terminal Region Truncation, or C-Terminal Region Truncation Rev1
Mutant Rescues CSR in Rev1/ B Cells
CSR to IgG1 in Rev1+/+ and Rev1/ B cells transduced with empty S-003 retrovirus or S-003 retrovirus expressing wild-type human Rev1 (includes the
N-terminal region containing the BRCT domain; the central region containing the D570E571 motif [which is critical for catalytic activity], the DNA-binding motif,
and the Hsp90-binding motif; and the C-terminal region containing the TLS polymerase interaction domain), catalytically inactive Rev1D570A/E571A mutant
(containing two point mutations at the D570E571 motif, inactivating Rev1 catalytic activity), C-terminal region deletion Rev11-827 mutant (retaining central and
N-terminal regions), N-terminal region deletion Rev1333-1251 mutant (retaining central and C-terminal regions), and central region deletion Rev1D334-826 mutant
(retaining N-terminal and C-terminal regions).Rev1+/+ andRev1/B cells were activated with LPS for 12 hr before transduction with retrovirus, and then cultured
for 48 hr with LPS plus IL-4.
(A) Schematic representation of human Rev1 and Rev1mutants encoded by retroviral constructs. The N-terminal, central, and C-terminal regions; BRCT domain;
and TLS polymerase interaction domain are indicated.
(B) CSR assessed by surface IgG1 expression in transduced (B220+GFP+)Rev1/B cells. Density plots show transduced B cells as a distinct (GFP+) population.
Histograms show the distribution of surface IgG1+ B cells among B220+GFP+ B cells. Data are from one representative experiment of four independent
experiments.
(C) GFP+ B cells were sorted by fluorescence-activated cell sorting (FACS) for analysis of circle Ig1-Cm (semiquantitative real-time PCR) and Im-Cg1 (real-time
qPCR) transcripts. Expression is normalized to Cd79b expression and presented as the ratio of expression in Rev1/ to Rev1+/+ B cells (set as one). **p < 0.001,
paired t test. Data are from four independent experiments (mean and SEM).
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mechanisms that underpin CSR and V(D)J SHM,which aremedi-
ated by separate AID domains (Shinkura et al., 2004), and the
different requirements for the induction of these two processes
(Zan et al., 1999, 2000, 2003). Rev1’s distinct functions are
mediated by discrete regions (Guo et al., 2006; Pozo et al.,
2011). The N-terminal region contains the BRCT domain; the
central region comprises the DNA-binding, Hsp90-binding, and
ubiquitin-binding motifs, in addition to the DE motif (D570E571
in human Rev1), which is critical for catalytic activity; and the
C-terminal region includes the PCNA interaction and TLS poly-
merase interaction domains. As we have shown here, enforced
expression of our N-terminal and C-terminal Rev1 truncation
mutants in Rev1/ B cells (both truncation mutants included
the full central region) restored CSR to levels comparable to
that of Rev1+/+ B cells, whereas the construct lacking the central
(DNA-binding) region did not. Rescue of CSRwas not dependent
on the Rev1 DE motif within this central region, which argues
strongly for a noncatalytic (scaffold) function for Rev1 in CSR.
Further, our BiFC assays unequivocally showed that Rev1 inter-
acts directly with Ung and does so through the conserved Ung
WxxF motif. This motif was found to be important for CSR, and
was hypothesized to mediate the interaction of Ung with a puta-
tive CSR cofactor (Begum et al., 2009), which we surmise here to
be Rev1.
As we have shown here, Rev1 promotes Ung recruitment/
stabilization to/on S region DNA and dU glycosylation in switch-
ing B cells. Rev1 localization to S regions required AID but not
Ung, whereas Ung recruitment to S regions required Rev1.
This Rev1 function would be made possible by the ability of
Rev1 to recognize and bind to dU-containing DNA, as suggested
by Rev1-mediated insertion of dC across from dU in DNA
synthesis (Zhang et al., 2002). Accordingly, our experiments
proved that the central region of Rev1, which contains the
DNA-binding domain, is critical for Rev1 function in CSR. In S
regions, Rev1 would be recruited by DNA-bound AID either
directly, as suggested by our preliminary modeling (http://
hexserver.loria.fr; E.J. Pone and P.C., unpublished data), or indi-
rectly, e.g., through Hsp90. Indeed, Hsp90 can bind to and stabi-
lize AID in CSR (Orthwein et al., 2010) and can specifically bind to
Rev1 to yield stable and/or functional form(s) of Rev1 (Pozo et al.,
2011). In contrast to a direct Ung-Rev1 interaction, Ung is unable
to bind AID (Ranjit et al., 2011), further suggesting that the puta-
tive stabilization of Ung on S region DNA by AID occurs, at least
in part, through Rev1. Thus, Rev1 would be recruited by AID to S
region DNA, and would interact directly with both dU and Ung,
thereby forming a complex within which Ung would stably asso-
ciate with and glycosylate dU for CSR to unfold.
Rev1/ B cells displayed normal cell cycle and proliferation,
indicating that the CSR reduction reflected an inherent defect
of the CSR machinery. The normal levels of germline IH-CH tran-
scripts in Rev1/ B cells suggested that the defect in CSR was
not due to alterations in chromatin accessibility at S regions.
Because Rev1 can associate with TLS DNA polymerase z, which
consists of the catalytic Rev3 and the regulatory Rev7 subunits,
to facilitate polymerase z function, we could not rule out the
possibility that Rev1 also contributes to CSR by promoting the
activity of Rev3, which has been suggested to catalyze fill-in
reactions in the course of CSR-associated DSB repair by nonho-Cell Remologous end-joining (Schenten et al., 2009). Nevertheless, our
demonstrations of (1) further reduced CSR in double-knockout
Rev1/Msh2/ B cells as compared with Rev1/Msh2+/+ B
cells; (2) the predominance of dC/dG transitions at S region
mutations in Rev1/ B cells, a pattern evocative of that of
Ung/ B cells but different from that of human and mouse B
cells deficient in DNA polymerase h (loss of dA/dT mutations;
Neuberger and Rada, 2007), a TLS polymerase that has been
suggested to be recruited to Ig V(D)J region DNA by Rev1 during
SHM (Hicks et al., 2010); and (3) the direct interaction of Rev1
with Ung all support the notion that Rev1 mediates CSR mainly
through its interaction with Ung. The residual CSR we detected
in the Rev1/Msh2/ B cells may reflect a residual recruit-
ment/stabilization of Ung to/on S region DNA that was indepen-
dent of Rev1. Indeed, as we have shown here, overall CSR in
Rev1/ B cells was significantly impaired but was not virtually
abrogated as it was in Ung/ B cells. Accordingly, the DNA
dU glycosylation activity of Rev1/Ung+/+ B cell extracts was
25% of that in Rev1+/+Ung+/+; that in Rev1+/+Ung/ was 5%
of the dU glycosylation in Rev1+/+Ung+/+ B cells.
In CSR, both the generation and repair of DSBs would entail
multiple sequential enzymatic reactions on the recombining S
region DNA. They would depend on the formation of amacromo-
lecular complex within which (nonenzymatic) scaffold elements,
such as 14-3-3 and RPA, and enzymatic elements with scaffold
functions, such as Rev1 and possibly AID, stabilize themselves
and other CSR factors on S regions. After dC deamination, AID
likely persists on the IgH locus (Larijani et al., 2007) and acts
a scaffold for other factors, including Rev1 (Xu et al., 2012).
Rev1 functions as a legitimate scaffold protein in CSR: it
comprises different protein-interaction domains (for Ung and
possibly AID) and coordinates the assembly of at least one rele-
vant molecular component, Ung, in a macromolecular complex
to increase the efficiency of a specific biological process, dU
glycosylation. Accordingly, RPA also directly interacts with
Ung, although deletion of the RPA-binding domains in the N
terminus of Ung does not impair CSR (Begum et al., 2009).
Ung molecules with both truncation of the N terminus and muta-
tions of the WxxF motif, which as we have shown here is critical
for Rev1 interaction, or of D145 and N204 in the catalytic center
failed to mediate CSR (Begum et al., 2009), suggesting that both
RPA and Rev1 are required for full function of Ung in CSR. Thus,
Rev1 together with Ung likely contributes to a DNA-protein
macromolecular complex that also includes AID, 14-3-3, and
RPA, and is central to the generation and resolution of S region
DSBs.EXPERIMENTAL PROCEDURES
Mice
Rev1/ mice were generated by Dr. Niels de Wind (Leiden University,
Netherlands) by deleting Rev1 exon 10, which encodes residues 557–609,
including the conserved S(C/I)DE amino acid sequence that is essential for
catalytic activity (Jansen et al., 2006). Both the catalytic domain and the
C-terminal domain, which interacts with other TLS polymerases, are absent
in thesemice (Jansen et al., 2006). Cells fromRev1/mice express only short-
ened Rev1 transcripts and no Rev1 protein.Msh2/ mice (Nikitin et al., 2002)
were obtained from Dr. Wen-Hwa Lee (University of California, Irvine, CA).
Ung/ mice (Nilsen et al., 2000) were obtained from Dr. T. Lindahl (Cancerports 2, 1220–1232, November 29, 2012 ª2012 The Authors 1229
Research UK London Research Institute, South Mimms, UK). Rev1/ and
Ung/ mice were on a mixed C57BL/6-129 background, and Msh2/ mice
were on a C57BL/6 background. We generated double-knockout Rev1/
Msh2/ mice by crossbreeding Rev1/ withMsh2/ mice. The Institutional
Animal Care and Use Committee of the University of California, Irvine,
approved all of the animal experiments.
NP16-CGG Immunization and Titration of Total and NP-Binding IgM
and IgG1
Rev1/ and Rev1+/+ mice (8–10 weeks old) were immunized with 100 mg of
NP16-CGG (16 molecules of NP coupled to one molecule of chicken g-globulin
(Biosearch Technologies) in Imject alum (Pierce) for B cell and NP antibody
studies, as previously described (Park et al., 2009; White et al., 2011).
B and T Cells
B cells (B220+), CD4+ and CD8+ T cells, dead B cells, germinal center
(PNAhi) B cells, plasma cells (B220lo CD138+), and NP-binding CD38hi
IgG1+memory B cells were identified and analyzed in single-cell suspensions
using a FACSCalibur flow cytometer (BD Biosciences) and specific mAbs.
Germinal center (PNAhi B220+) B cells expressing IgG1 or IgA in vivo were
determined by flow cytometry (Mai et al., 2010; Park et al., 2009). We deter-
mined the cell cycle of in vitro stimulated B cells by analyzing the correlated
expression of total DNA (indicated by 7-AAD intercalation) and incorporated
bromodeoxyuridine (BrdU) levels using a BD PharMingen allophycocyanin
(APC) BrdU FlowKit (BDBiosciences) according to themanufacturer’s instruc-
tions. We analyzed the proliferation of in vitro stimulated B cells using a Cell-
Trace CFSE Cell Proliferation Kit (Molecular Probes). Proliferation of B cells
in mice immunized with NP16-CGG was measured by BrdU incorporation.
CSR
B cells were stimulated with LPS (5 mg/ml) or CD154 (1 U/ml, obtained by
expression of mouse CD154 on membranes of Sf21 insect cells) plus nil or
appropriate cytokine(s) to induce CSR to different isotypes (Park et al.,
2009; Pone et al., 2012a), and then analyzed for surface Ig. Titers of IgG1,
IgG2a, IgG2b, IgG3, IgA, and IgE in culture supernatants of in vitro stimulated
B cells were measured using specific ELISAs as previously described (Park
et al., 2009; White et al., 2011).
Real-Time qPCR
Germline IH-CH, circle IH-Cm, post-recombination Im-CH, HoxC4, Aicda, Rev1,
Ung, and 14-3-3g, Cd79b and Gapdh transcripts were analyzed by real-time
qPCR using specific primers as described previously (Park et al., 2009; White
et al., 2011) or listed in Extended Experimental Procedures.
DC-PCR
B cells were stimulated with LPS or LPS plus IL-4 for 4 days for isolation of
genomic DNA and detection of recombinant Sm-Sg1 and Sm-Sg3 DNA by
DC-PCR (Wang et al., 2009).
Somatic Mutations in Sm Region DNA
Peyer’s patch B cells switch and accumulate mutations in the Sm region at
a high rate (Delbos et al., 2005). Somatic mutations in Sm regions were
analyzed using genomic DNA prepared from Peyer’s patch B cells from
Rev1+/+ Ung+/+ and Rev1/ Ung+/+ littermates and age-matched Rev1+/+
Ung/ mice.
ChIP
ChIP assays were performed as previously described (Kim et al., 2004; Park
et al., 2009; Schaffer et al., 2003; Xu et al., 2010) using rabbit Abs to Rev1
(H-300; Santa Cruz Biotechnology) and Ung (FL-313; Santa Cruz
Biotechnology).
BiFC
The BiFC assay used to analyze the direct interaction of Rev1 with Ung was
adapted from our previously reported method (Xu et al., 2010). Briefly, 5 3
105 HeLa cells were transiently transfected using Lipofectamine (Invitrogen)
with plasmids (0.5 mg each) expressing HA-(human) Rev1-YFP155-238 and1230 Cell Reports 2, 1220–1232, November 29, 2012 ª2012 The AutFlag-Ung-YFP1-154, Flag-Ung1-151-YFP1-154, or Flag-Ung85-313-YFP1-154
proteins, or Ung WxxF mutants Flag-UngW231A-YFP1-154, Flag-UngF234G-
YFP1-154, or Flag-UngF234Q-YFP1-154, which were generated using the Rev1
interaction-proficient Ung85-313 truncation mutant (a human Ung molecule
that lacks residues 1–84 and is equivalent to the mouse Ung lacking residues
1–86) as the starting construct. Cells were washed 24 hr after transfection,
stained with 7-AAD, and analyzed by flow cytometry.
DNA-dU Glycosylation
Ung activity was measured using a 50-[32P]-labeled double-stranded oligonu-
cleotide with an internal dU:dG mispair as previously reported (Di Noia and
Neuberger, 2002; Zan and Casali, 2008).
Rev1 and Rev1 Mutant Constructs and Enforced Expression
Human Rev1 cDNA was prepared from mRNA of human peripheral blood
mononuclear cells. The catalytically inactive mutant Rev1D570A/E571A, which
contained two point mutations at the D570E571 motif (D570A and E571A;
human Rev1 D570E571 is equivalent to mouse Rev1 D568E569 [Masuda
et al., 2009; Ross et al., 2005]) was generated by site-directed mutagenesis.
The constructs encoding the C-terminal deletion mutant Rev11-827 (retaining
the central and N-terminal regions), the N-terminal deletion mutant
Rev1333-1251 (retaining the central and C-terminal regions), and the central
region deletion mutant Rev1D334-826 (retaining the N-terminal and C-terminal
regions) were generated by PCR. Wild-type and mutant Rev1 cDNAs were
cloned into the S-003 retroviral expression vector (Sayegh et al., 2003;
a kind gift fromDr. C.Murre, University of California, San Diego). For the gener-
ation of retrovirus, the constructs were transfected along with the pCL-Eco
retrovirus-packaging vector (Imgenex) into the HEK293T cell line, which was
pretreated with 25 mM chloroquine, using the ProFection Mammalian Trans-
fection system (Promega). The retroviral constructs were used to transduce
Rev1+/+ and Rev1/ B cells as previously described (Sayegh et al., 2003).
Briefly, B cells were activated with LPS for 12 hr and then transduced with
retrovirus. We then stimulated the transduced B cells with LPS plus IL-4 for
48 hr before analyzing CSR to IgG1 by semiquantitative real-time PCR and
real-time qPCR.
Immunohistochemistry
Paraffin-embedded human tonsil surgical specimens were serially sectioned
with a cryostat at 6 mm onto glass slides and stained as previously described
(Xu et al., 2010).
Statistical Analyses
Differences in the spectrum of mutations in Rev1+/+ and Rev1/ mice were
analyzed with the chi-squared test. Differences in Ig titers, CSR, and mRNA
expression were analyzed with paired or unpaired t tests.
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